• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管平滑肌细胞衍生的转化生长因子-β促进活化的、动脉粥样硬化斑块样巨噬细胞的成熟。

Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.

机构信息

From the Department of Medicine, Division of Renal Diseases and Hypertension (H.N.H., J.P., M.C.M.W.-E., R.A.N.), Department of Pharmacology (A.O., M.C.M.W.-E., R.A.N.), and Cardiovascular and Pulmonary Research Laboratory (M.C.M.W.-E., R.A.N.), University of Colorado Denver, Aurora.

出版信息

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):877-86. doi: 10.1161/ATVBAHA.114.303214. Epub 2014 Feb 13.

DOI:10.1161/ATVBAHA.114.303214
PMID:24526697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3966963/
Abstract

OBJECTIVE

To define the contribution of vascular smooth muscle cell (SMC)-derived factors to macrophage phenotypic modulation in the setting of vascular injury.

APPROACH AND RESULTS

By flow cytometry, macrophages (M4) were the predominant myeloid cell type recruited to wire-injured femoral arteries, in mouse, compared with neutrophils or eosinophils. Recruited macrophages from injured vessels exhibited a distinct expression profile relative to circulating mononuclear cells (peripheral blood monocytes; increased: interleukin-6, interleukin-10, interleukin-12b, CC chemokine receptor [CCR]3, CCR7, tumor necrosis factor-α, inducible nitric oxide synthase, arginase 1; decreased: interleukin-12a, matrix metalloproteinase [MMP]9). This phenotype was recapitulated in vitro by maturing rat bone marrow cells in the presence of macrophage-colony stimulating factor and 20% conditioned media from cultured rat SMC (sMϕ) compared with maturation in macrophage-colony stimulating factor alone (M0). Recombinant transforming growth factor (TGF)-β1 recapitulated the effect of SMC conditioned media. Macrophage maturation studies performed in the presence of a pan-TGF-β neutralizing antibody, a TGF-β receptor inhibitor, or conditioned media from TGF-β-depleted SMCs confirmed that the SMC-derived factor responsible for macrophage activation was TGF-β. Finally, the effect of SMC-mediated macrophage activation on SMC biology was assessed. SMCs cocultured with sMϕ exhibited increased rates of proliferation relative to SMCs cultured alone or with M0 macrophages.

CONCLUSIONS

SMC-derived TGF-β modulates the phenotype of maturing macrophages in vitro, recapitulating the phenotype found in vascular lesions in vivo. SMC-modulated macrophages induce SMC activation to a greater extent than control macrophages.

摘要

目的

确定血管平滑肌细胞(SMC)衍生因子在血管损伤情况下对巨噬细胞表型调节的贡献。

方法和结果

通过流式细胞术,与中性粒细胞或嗜酸性粒细胞相比,在小鼠的线损伤股动脉中,巨噬细胞(M4)是募集的主要髓样细胞类型。与循环单核细胞(外周血单核细胞相比,来自损伤血管的募集巨噬细胞表现出明显不同的表达谱:白细胞介素-6、白细胞介素-10、白细胞介素-12b、CC 趋化因子受体 [CCR]3、CCR7、肿瘤坏死因子-α、诱导型一氧化氮合酶、精氨酸酶 1 增加;白细胞介素-12a、基质金属蛋白酶 [MMP]9 减少)。在存在巨噬细胞集落刺激因子和 20%培养的大鼠 SMC(sMϕ)条件培养基的情况下,体外培养大鼠骨髓细胞可重现这种表型,而在仅存在巨噬细胞集落刺激因子的情况下(M0)则不能。重组转化生长因子(TGF)-β1 重现了 SMC 条件培养基的作用。在存在泛 TGF-β 中和抗体、TGF-β 受体抑制剂或 TGF-β 耗尽的 SMC 条件培养基的情况下进行的巨噬细胞成熟研究证实,负责激活巨噬细胞的 SMC 衍生因子是 TGF-β。最后,评估了 SMC 介导的巨噬细胞激活对 SMC 生物学的影响。与单独培养的 SMC 或与 M0 巨噬细胞共培养的 SMC 相比,与 sMϕ 共培养的 SMC 表现出更高的增殖率。

结论

SMC 衍生的 TGF-β 体外调节成熟巨噬细胞的表型,重现体内血管病变中发现的表型。与对照巨噬细胞相比,SMC 调节的巨噬细胞更能诱导 SMC 激活。

相似文献

1
Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.血管平滑肌细胞衍生的转化生长因子-β促进活化的、动脉粥样硬化斑块样巨噬细胞的成熟。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):877-86. doi: 10.1161/ATVBAHA.114.303214. Epub 2014 Feb 13.
2
Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.G 蛋白信号调节因子 5 可防止平滑肌细胞增殖并减轻内膜增生。
Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):317-27. doi: 10.1161/ATVBAHA.115.305974. Epub 2015 Dec 10.
3
Adipolin/CTRP12 protects against pathological vascular remodelling through suppression of smooth muscle cell growth and macrophage inflammatory response.脂联素/CTRP12 通过抑制平滑肌细胞生长和巨噬细胞炎症反应来防止病理性血管重构。
Cardiovasc Res. 2020 Jan 1;116(1):237-249. doi: 10.1093/cvr/cvz074.
4
LMO7 Is a Negative Feedback Regulator of Transforming Growth Factor β Signaling and Fibrosis.LMO7 是转化生长因子 β 信号和纤维化的负反馈调节剂。
Circulation. 2019 Jan 29;139(5):679-693. doi: 10.1161/CIRCULATIONAHA.118.034615.
5
Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.巨噬细胞中的盐皮质激素受体缺陷通过SGK1-AP1/NF-κB途径抑制内膜增生并抑制巨噬细胞炎症。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):874-85. doi: 10.1161/ATVBAHA.115.307031. Epub 2016 Mar 10.
6
Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.Epac1 缺乏可减弱血管平滑肌细胞迁移和内膜形成。
Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2617-25. doi: 10.1161/ATVBAHA.115.306534. Epub 2015 Oct 1.
7
Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.巨噬细胞衍生的 MMP-8 决定从动脉外膜干细胞/祖细胞分化为平滑肌细胞,并促进内膜增生。
Cardiovasc Res. 2020 Jan 1;116(1):211-225. doi: 10.1093/cvr/cvz044.
8
Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation. sonic hedgehog 依赖性激活外膜成纤维细胞促进内膜新生。
Cardiovasc Res. 2017 Nov 1;113(13):1653-1663. doi: 10.1093/cvr/cvx158.
9
Human C-reactive protein enhances thrombus formation after neointimal balloon injury in transgenic rabbits.人 C 反应蛋白增强转基因兔血管损伤后血栓形成。
J Thromb Haemost. 2011 Jan;9(1):201-8. doi: 10.1111/j.1538-7836.2010.04086.x.
10
Macrophage (Drp1) Dynamin-Related Protein 1 Accelerates Intimal Thickening After Vascular Injury.巨噬细胞(Drp1)动力相关蛋白 1 加速血管损伤后的内膜增厚。
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):e214-e226. doi: 10.1161/ATVBAHA.120.314383. Epub 2020 Jun 4.

引用本文的文献

1
Immune and Vascular Function in Cardiometabolic Disorders: Interplay With Sex Differences and Impact on Incretin Therapy.心脏代谢疾病中的免疫与血管功能:与性别差异的相互作用及对肠促胰岛素治疗的影响
Acta Physiol (Oxf). 2025 Sep;241(9):e70091. doi: 10.1111/apha.70091.
2
Pentagalloyl glucose induces anti-inflammatory macrophage polarization - suppressing macrophage mediated vascular cell dysfunction and TGF-β secretion.没食子酰葡萄糖诱导抗炎型巨噬细胞极化——抑制巨噬细胞介导的血管细胞功能障碍和 TGF-β 分泌。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241276894. doi: 10.1177/03946320241276894.
3
Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.新型洞察与巨噬细胞在肺动脉高压中的新治疗潜能。
Respir Res. 2024 Mar 30;25(1):147. doi: 10.1186/s12931-024-02772-8.
4
Global trends and Frontier topics about vascular smooth muscle cells phenotype switch: A bibliometric analysis from 1999 to 2021.血管平滑肌细胞表型转换的全球趋势与前沿主题:1999年至2021年的文献计量分析
Front Pharmacol. 2022 Nov 14;13:1004525. doi: 10.3389/fphar.2022.1004525. eCollection 2022.
5
Endothelial cell-derived pro-fibrotic factors increase TGF-β1 expression by smooth muscle cells in response to cycles of hypoxia-hyperoxia.内皮细胞衍生的促纤维化因子增加了缺氧-复氧刺激平滑肌细胞表达 TGF-β1。
Biochim Biophys Acta Mol Basis Dis. 2022 Jan 1;1868(1):166278. doi: 10.1016/j.bbadis.2021.166278. Epub 2021 Oct 1.
6
TET2 Protects Against Vascular Smooth Muscle Cell Apoptosis and Intimal Thickening in Transplant Vasculopathy.TET2 可防止移植血管病中的血管平滑肌细胞凋亡和内膜增厚。
Circulation. 2021 Aug 10;144(6):455-470. doi: 10.1161/CIRCULATIONAHA.120.050553. Epub 2021 Jun 11.
7
Cyclic Stretch Induces Vascular Smooth Muscle Cells to Secrete Connective Tissue Growth Factor and Promote Endothelial Progenitor Cell Differentiation and Angiogenesis.周期性拉伸诱导血管平滑肌细胞分泌结缔组织生长因子并促进内皮祖细胞分化和血管生成。
Front Cell Dev Biol. 2020 Dec 9;8:606989. doi: 10.3389/fcell.2020.606989. eCollection 2020.
8
PDGFRA in vascular adventitial MSCs promotes neointima formation in arteriovenous fistula in chronic kidney disease.血小板衍生生长因子受体 A 在血管外膜间充质干细胞中促进慢性肾脏病动静脉瘘中的新生内膜形成。
JCI Insight. 2020 Nov 5;5(21):137298. doi: 10.1172/jci.insight.137298.
9
Mechanistic regulation of SPHK1 expression and translocation by EMAP II in pulmonary smooth muscle cells.内皮单核激活肽 II 调控肺平滑肌细胞中鞘氨醇激酶 1 的表达和转位的机制。
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158789. doi: 10.1016/j.bbalip.2020.158789. Epub 2020 Aug 7.
10
A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development.体内组织工程血管移植物发育的计算生物化学 - 机械模型。
Integr Biol (Camb). 2020 Apr 14;12(3):47-63. doi: 10.1093/intbio/zyaa004.

本文引用的文献

1
Choosing Smads: smooth muscle origin-specific transforming growth factor-β signaling.选择Smads:平滑肌起源特异性转化生长因子-β信号传导
Circ Res. 2013 Sep 27;113(8):946-8. doi: 10.1161/CIRCRESAHA.113.302123.
2
Biological responses in stented arteries.支架内动脉的生物学反应。
Cardiovasc Res. 2013 Jul 15;99(2):353-63. doi: 10.1093/cvr/cvt115. Epub 2013 May 10.
3
TGF-β signaling in myeloid cells is required for tumor metastasis.髓系细胞中的 TGF-β 信号通路对于肿瘤转移是必需的。
Cancer Discov. 2013 Aug;3(8):936-51. doi: 10.1158/2159-8290.CD-12-0527. Epub 2013 May 9.
4
Phenotypic polarization of macrophages in atherosclerosis.动脉粥样硬化中巨噬细胞的表型极化。
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1120-6. doi: 10.1161/ATVBAHA.112.300173. Epub 2013 May 2.
5
Local drug delivery to prevent restenosis.局部药物递送预防再狭窄。
J Vasc Surg. 2013 May;57(5):1403-14. doi: 10.1016/j.jvs.2012.12.069.
6
Macrophage plasticity and polarization in tissue repair and remodelling.组织修复和重塑中的巨噬细胞可塑性和极化。
J Pathol. 2013 Jan;229(2):176-85. doi: 10.1002/path.4133. Epub 2012 Nov 29.
7
Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling.损伤激活的转化生长因子β控制间充质干细胞的动员以进行组织重塑。
Stem Cells. 2012 Nov;30(11):2498-511. doi: 10.1002/stem.1208.
8
Inflammation and vascular injury: basic discovery to drug development.炎症和血管损伤:从基础发现到药物研发。
Circ J. 2012;76(8):1811-8. doi: 10.1253/circj.cj-12-0801. Epub 2012 Jul 30.
9
Transforming growth factor-β and smooth muscle differentiation.转化生长因子-β与平滑肌分化
World J Biol Chem. 2012 Mar 26;3(3):41-52. doi: 10.4331/wjbc.v3.i3.41.
10
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.